by thefutureofdermatology
Join Dr. Faranak Kamangar, MD, every week as she chats with various guests about the future of dermatology. Each week, Dr. Kamangar and her guests cover topics from psoriasis, to eczema, to skin care, to AI, and more. Whether you’re a doctor or a patient, these episodes provide valuable information about your skin and how to navigate the world of dermatology.
Language
🇺🇲
Publishing Since
9/19/2023
Email Addresses
0 available
Phone Numbers
0 available
April 29, 2025
Summary In this episode of the Future of Dermatology podcast, Dr. Faranak Kamangar discusses the critical relationship between dermatology and metabolic dysfunction. This podcast episode explores how conditions like obesity and insulin resistance can manifest in dermatological symptoms, emphasizing the importance of recognizing these signs in clinical practice. Also highlighted is the role of diet in exacerbating skin conditions and the need for dermatologists to understand metabolic health to improve patient outcomes. Dr. Kamangar concludes with insights into future directions in dermatology, particularly regarding the treatment of metabolic-related skin diseases. Takeaways - Nearly 70% of adults are overweight or obese in the US.- Sarcopenic obesity is often overlooked in metabolic assessments.- Insulin resistance should be tested in patients with inflammatory skin conditions.- Diet plays a significant role in metabolic dysfunction and skin health.- Psoriasis is closely linked to metabolic disorders and insulin resistance.- Weight loss can improve psoriasis symptoms significantly.- Insulin potentiates inflammation, affecting skin conditions.- Hydradenitis suppurativa is an independent risk factor for insulin resistance.- Understanding metabolism is crucial for effective dermatological treatments.- Metabolic dysfunction accelerates skin aging and inflammation. Chapters 00:00 - Introduction to Dermatometabolic Series02:46 - Understanding Metabolic Dysfunction10:35 - Insulin Resistance and Its Implications17:00 - The Role of Diet in Dermatology22:53 - Metabolic Disease and Skin Conditions25:35 - Conclusion and Future Directions
April 25, 2025
Summary Join Dr. Faranak Kamangar as she embarks on the podcast journey of dermatometabolics. For the next few weeks she'll explore various topics in the realm of dermatometabolics such as insulin resistance, GLP and GIP, and skin care. Stay tuned!
April 22, 2025
Summary In this episode of the Future of Dermatology Podcast, we revisit the 2024 SF Derm Society's Annual Conference where Dr. Jason Hawkes discusses the complexities of urticaria, including its definitions, types, and the role of mast cells in the condition. This presentation highlights the differences between acute and chronic urticaria, the importance of understanding autoimmunity in relation to urticaria, and the latest treatment approaches, including innovative therapies like Omalizumab. The episode concludes with a call to action for dermatologists to embrace the treatment of urticaria and engage with their patients effectively. Takeaways - Urticaria is often misunderstood, but it has exciting aspects to explore.- Acute urticaria lasts less than six weeks, while chronic urticaria lasts longer.- Chronic spontaneous urticaria (CSU) is often idiopathic and can last for years.- Mast cells play a central role in the pathophysiology of urticaria.- Autoimmunity is a common theme in patients with urticaria, especially in women.- Diagnosis of urticaria is primarily clinical, with no specific lab tests required.- Many patients do not respond to standard antihistamine treatments.- Omalizumab is a powerful treatment option for chronic urticaria.- Anaphylaxis is rare in patients treated with Omalizumab for urticaria.- Dermatologists should feel confident in treating urticaria with available therapies. Chapters 00:00 - Introduction to the Future of Dermatology Podcast00:57 - Understanding Urticaria: Definitions and Types03:50 - Differentiating Acute and Chronic Urticaria06:13 - The Role of Mast Cells in Urticaria09:03 - Autoimmunity and Urticaria: Comorbidities and Testing10:59 - Diagnosis and Treatment Approaches for Urticaria13:52 - Innovative Therapies: Omalizumab and Beyond15:42 - Conclusion and Call to Action
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at [email protected] for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.
